— Know what they know.
Not Investment Advice
Also trades as: 1099.HK (HKSE) · $vol 11M · SHTDF (OTC) · $vol 0M

SHTDY OTC

Sinopharm Group Co. Ltd.
1W: -0.8% 1M: -3.9% 3M: -14.9% YTD: -25.9% 1Y: -20.7% 3Y: -30.0% 5Y: -17.5%
$9.35
+0.02 (+0.21%)
 
Weekly Expected Move ±2.6%
$9 $9 $9 $10 $10
OTC · Healthcare · Medical - Distribution · Tech Score Strong Sell · Power 43 · $5.8B mcap · 255M float · 0.060% daily turnover · Short 27% of daily vol

Income Trends

Revenue
$559.5B -4.3% ▼
5Y CAGR: +4.2%
Gross Profit
$40.1B -9.4% ▼
5Y CAGR: -0.1%
Operating Income
$16.2B +0.1% ▲
5Y CAGR: -1.8%
Net Income
$7.0B -1.3% ▼
5Y CAGR: -0.6%
EPS (Diluted)
$11.10 -1.8% ▼
5Y CAGR: -0.8%
EBITDA
$20.4B +1.0% ▲
5Y CAGR: -2.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$521.1B$552.1B$596.6B$584.5B$559.5B
YoY Growth+14.2%+6.0%+8.0%-2.0%-4.3%
Cost of Revenue$477.0B$504.7B$548.1B$540.3B$519.4B
Gross Profit$44.1B$47.4B$48.5B$44.3B$40.1B
Gross Margin8.5%8.6%8.1%7.6%7.2%
R&D Expenses$0$0$0$0$0
SG&A Expenses$23.2B$24.9B$26.1B$25.6B$23.9B
Operating Expenses$24.3B$26.8B$28.3B$28.1B$23.9B
Operating Income$19.7B$20.6B$20.2B$16.2B$16.2B
Operating Margin3.8%3.7%3.4%2.8%2.9%
Interest Expense$3.8B$3.5B$3.0B$2.7B$2.4B
Income Before Tax$17.0B$18.6B$19.5B$14.0B$14.4B
Tax Expense$3.9B$4.2B$4.5B$3.6B$3.9B
Net Income$7.8B$8.5B$9.1B$7.0B$7.0B
Net Margin1.5%1.5%1.5%1.2%1.2%
EPS (Diluted)$12.45$13.65$14.50$11.30$11.10
EBITDA$24.7B$26.2B$26.9B$20.2B$20.4B
Shares Outstanding622M624M624M624M624M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms